ArticleCancer management and research2018
CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo.
Wei Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled itcites it